EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Effectiveness of Influenza Vaccine in Wuhan, China During the 2024–2025 Season: A Test-Negative Case–Control Study

Pei Zhang iD, Xiaokun Yang iD, Banghua Chen iD

Vaccines · 06.03.2026 · 14 (3) · 243

DOI: 10.3390/vaccines14030243 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Vaccines, online erschienen am 06.03.2026. Verfasst von Pei Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Office of Preventive Medicine Association, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vaccine Effectiveness (VE) provides an important indicator of vaccine performance under real-world conditions. However, evidence regarding influenza VE in Wuhan remains limited. This study applied a test-negative case–control design to estimate the effectiveness of influenza vaccination during the 2024–2025 influenza season in Wuhan.

Methods

A test-negative case–control design was conducted among patients presenting with influenza-like illness (ILI) at outpatient and emergency departments of 41 healthcare institutions in Wuhan. All participants underwent influenza virus real-time reverse transcription polymerase chain reaction (RT-PCR) testing and were categorized as cases (RT-PCR positive) or controls (RT-PCR negative) based on laboratory results.

Results

The analysis included 23,302 RT-PCR-confirmed influenza cases and 99,424 test-negative controls. The overall adjusted VE was 35% (95% CI: 30–40%). VE differed across age group, with higher estimates observed among adults aged 19–59 years (63%; 95% CI: 50–73%) and 60–69 years (60.7%; 95% CI: 46–72%), whereas lower effectiveness was observed among children aged 0.5–5 years (25%; 95% CI: 17–33%) and 6–18 years (25%; 95% CI: 14–36%). Similar protection was observed among individuals vaccinated in both the 2023–2024 and 2024–2025 seasons (42%; 95% CI: 28–54%) and those vaccinated in the 2024–2025 season only (40%; 95% CI: 36–45%), whereas VE was lower among individuals vaccinated only during the previous season (20%; 95% CI: 14–26%). VE also varied by vaccination timing, with the highest effectiveness observed among individuals vaccinated in November 2024 (46.1%; 95% CI: 36.4–54.6%).

Conclusions

Influenza vaccination provided measurable protection during the 2024–2025 season in Wuhan. Greater protection was observed among individuals vaccinated in consecutive seasons or during the current season compared with those vaccinated only in the prior season. Vaccination administered in November was associated with the highest effectiveness, highlighting the importance of appropriate vaccination timing.

Schlagwörter

Stichwörter der Autor:innen

influenzatest-negative designvaccine effectiveness

Autor:innen und Institutionen

  • Office of Preventive Medicine Association, Henan Center for Disease Control and Prevention, Zhengzhou 450016, China.
  • Wuhan Center for Disease Control and Prevention, Wuhan 430024, China.
  • Chinese Field Epidemiology Training Program, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Beijing 100050, China.
  • Division of Infectious Disease Control and Prevention, Chinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine), Beijing 102206, China.

ORCID-Profile: Pei Zhang, Xiaokun Yang, Banghua Chen

Förderung

  • the National Key Research and Development Program of China
  • National Key Research and Development Program of China

Zitieren

APA

Zhang, P., Yang, X., & Chen, B. (2026). Effectiveness of Influenza Vaccine in Wuhan, China During the 2024–2025 Season: A Test-Negative Case–Control Study. Vaccines, 14(3), 243. https://doi.org/10.3390/vaccines14030243

Vancouver

Zhang P, Yang X, Chen B. Effectiveness of Influenza Vaccine in Wuhan, China During the 2024–2025 Season: A Test-Negative Case–Control Study. Vaccines. 2026;14(3):243. doi:10.3390/vaccines14030243

BibTeX
@article{Zhang2026,
  author = {Zhang, Pei and Yang, Xiaokun and Chen, Banghua},
  title = {Effectiveness of Influenza Vaccine in Wuhan, China During the 2024–2025 Season: A Test-Negative Case–Control Study},
  journal = {Vaccines},
  year = {2026},
  volume = {14},
  number = {3},
  pages = {243},
  doi = {10.3390/vaccines14030243}
}
Kostenlos starten →